We took Waymo's new 'Ojai' minivan for a spin in San Francisco. It's less luxurious than the familiar Jaguar I-PACE sedan, ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Add Yahoo as a preferred source to see more of our stories on Google. The Ajax was seen in its first public running display at Tankfest 2024 at The Tank Museum in Dorset, but problems quickly emerged ...

AMSTERDAM, May 24 (Reuters) - Ajax Amsterdam clinched a berth in European club competition with a penalty shootout win over Utrecht in their ‌playoff at neutral Volendam on Sunday. Ajax qualified for ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

A former California Highway Patrol captain allegedly hired a hitman to kill her estranged husband — and now the wannabe assassin is on trial for capital murder Clay County Sheriff's Office; California ...

Eli Lilly LLY-1.21%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Eli Lilly & Co. agreed to buy closely held Ajax Therapeutics Inc. for as much as $2.3 billion in cash, part of its effort to build out a portfolio of breakthrough cancer therapies. Ajax’s lead ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

April 27 (Reuters) - Eli Lilly ⁠said ⁠on Monday it would ⁠buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ‌expand its oncology ...